Clinical activity of adenosine 2A receptor (A2AR) inhibitor CPI-444 is associated with tumor expression of adenosine pathway genes and tumor immune modulation Meeting Abstract
| Authors: | Hotson, A.; Powderly, J.; Emens, L.; Forde, P.; Hellman, M.; Fong, L.; Markman, B.; Hughes, B.; Goldman, J.; Sznol, M.; Mahadevan, D.; Kummar, S.; Brody, J.; Bonomi, P.; Luke, J.; Riese, M.; Owonikoko, T.; Loi, S.; Wiese, A.; Doebele, R.; Lee, J.; Gu, C.; Willingham, S.; Laport, G.; Miller, R.; McCaffery, I. |
| Abstract Title: | Clinical activity of adenosine 2A receptor (A2AR) inhibitor CPI-444 is associated with tumor expression of adenosine pathway genes and tumor immune modulation |
| Meeting Title: | 32nd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2017) |
| Journal Title: | Journal for ImmunoTherapy of Cancer |
| Volume: | 5 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2017 Nov 8-12 |
| Meeting Location: | National Harbor, MD |
| ISSN: | 2051-1426 |
| Publisher: | Biomed Central Ltd |
| Date Published: | 2017-11-07 |
| Start Page: | 86 |
| Language: | English |
| DOI: | 10.1186/s40425-017-0289-3 |
| PROVIDER: | manual |
| Notes: | Meeting Abstract: O4 -- Matthew Hellmann's last name is misspelled on the original publication |
